Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors

New bexagliflozin (Brenzavvy) will try to shake up the SGLT2 inhibitor market.

That’s because bexagliflozin will cost about $50/mo...versus about $600/mo for other SGLT2 inhibitors (dapagliflozin, etc).

But bexagliflozin won’t be covered by most payers yet...and it will only be available through a single online pharmacy at first. Expect distribution to broaden over the next couple months.